By further characterizing PSA-based tests in minority populations with homogenous, GS 3+3=6 (Grade Group 1) PCa, we can attempt to address risk stratification disparities by isolating and identifying contributing factors. This evidence concerns the gene KLK3 and posterior cortical atrophy.